God is our Guide                Number 1 site for helping reverse diseases on Planet Earth

 

      

 
Home
Diagnosis
Treatment
NaturalMakeup
Women Heart Risk
Women Killer Disease
Fibromyalgia
Healthy Vinegar
Diet anti-inflammatory
Burning Feet Home
Services Page
Hepatitis
Autoimmune diseases
Prognosis
Bible healing
Pemphagoid
Autoimmune self attack

Miss cidpusa page-2

AMYTOPHIC LATERAL SCLEROSIS

 Mammogram

SLE

Curry Powder

Tremor

 Scleroderma

Multiple Sclerosis treatment

Morgellons story

Antidepressants

CoEnzymeQ10

Graves disease

Cassava Plant & neuropathy

Morgellons Syndrome

Cancer and Bacteria

Cancer & Flaxseed oil

Cancer Mycoplasma

CMT

Miracle ITP

Hemolytic anemia

Cholesterol drugs & Bleeding

What is autoimmune

Coconut oil

   Pregnant Vaccine

  Women Toxic makeup

   ORGANIC CERTIFIED

Broccoli & Prostate Genes

Green TEA AND HEART DISEASE

Testicle Massage

Walnut oil

Cell death

Blood injection healing

Rheumatoid Story

Reverse all diseases

Bacteria

Immune response

Risk of heart disease & stroke 

Depression and breast cancer

Personality

Joint disorder clinic

Neurology Clinic

TMJ Clinic

Reduce  your weight

Anti-ageingCIDPUSA Foundation

  guide on alternatives treatment of disease please read our e-book 

 

 

 

Umbilical cord blood cell transplants may harbour Lou Gehrig’s cure

Washington, June 25 (ANI): Researchers from University of South Florida have revealed that umbilical cord blood cells transplants may offer a treatment for patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease.

Lou Gehrig’s disease is a progressive, usually fatal, neurodegenerative disease caused by the degeneration of motor neurons. It is the disorder that causes muscle weakness, atrophy throughout the body and respiratory failure three to five years after diagnosis.


During the study, researchers transplanted human umbilical cord blood (HUCB) cells into mouse models with ALS.

Cells were transplanted at three different dose strength levels — low, moderate and high — to determine the degree to which dose levels of transplanted cells might delay disease symptom progression and increase lifespan.

They found that the moderate-strength dose of HUCB cells was most effective in increasing lifespan and reducing disease progression.


“Our results demonstrate that treatment for ALS with an appropriate dose of mononuclear HUBC cells may provide a neuroprotective effect for motor neurons through active involvement of these cells in modulating the host immune inflammatory system response,” said Svitlana Garbuzova-Davis, the study’s lead author from the Centre of Excellence for Aging and Brain Repair at USF.

The research team said that modulating immune and inflammatory effectors with HUCB cells could have a protective effect on dying motor neurons.

However, the researchers said that the mechanism underlying the beneficial effect of hUBC cells for repairing diseased motor neurons in ALS still needs more clarification.

“Future studies should look at multiple injections of smaller doses over time, in order to help translate this research to clinical trials,” said co-author Paul R. Sanberg, PhD, DSc, director of the Centre.

The results are published online at PloS ONE (Public Library of Science).

atmospheric co2 levels on earth

 


 

 
 

  

Sand Bath

 Glutathione

 Sulphur Bath

 

 Shifa page